Telepathology: How Remote Diagnosis Works
How telepathology works: whole-slide imaging, remote frozen sections, second opinions, AI-assisted analysis, plus validation, QA, and reimbursement basics.
Telepathology is the practice of pathology at a distance: a specimen is prepared and digitized in one location, and a pathologist views and interprets it from another. Instead of shipping glass slides or requiring the pathologist to be physically present at the microscope, telepathology moves the image — most often as a high-resolution scan of the entire slide. It is used for intraoperative frozen-section consultations, expert second opinions, subspecialty coverage of smaller hospitals, quality assurance, and education, and it is the foundation on which AI-assisted digital pathology is being built.
What Telepathology Is
Pathologists diagnose disease by examining tissue and cells, traditionally through a microscope. Telepathology replaces the physical hand-off of glass slides with digital transmission of images. Three technical approaches have been used over the years:
- Static (store-and-forward) telepathology. Selected photomicrographs are captured and sent for review. Simple and inexpensive, but the remote pathologist sees only the fields someone else chose.
- Robotic microscopy. The remote pathologist drives a motorized microscope in real time, choosing fields and magnification. This solved the field-selection problem but is slower and has largely been superseded.
- Whole-slide imaging (WSI). A scanner digitizes the entire glass slide at high magnification, producing a "virtual slide" that can be panned and zoomed like an interactive map. WSI is now the dominant approach and the basis of what most people mean by digital pathology.
The distinction matters because the diagnostic claim differs. Reviewing a few static images for an informal opinion is very different from rendering a primary diagnosis — the official interpretation of record — from a digital slide. Primary diagnosis via WSI is now an established practice in the United States: the FDA has authorized whole-slide imaging systems for that purpose, and laboratories that adopt them must validate the technology in their own hands before going live.
How It Works in Practice
A typical WSI workflow looks like this. Tissue is processed, embedded, sectioned, and stained in the histology laboratory exactly as it always has been. The finished slide goes into a scanner, which captures the whole slide, commonly at the digital equivalent of 20x or 40x magnification. A single slide can produce an image file of a gigabyte or more, so labs invest in storage, network capacity, and image-management software that ties each virtual slide to the correct case in the laboratory information system.
The reviewing pathologist opens the case in a viewer on a validated display, navigates the virtual slide, and signs out the report the same way as with glass. For real-time consultations, two pathologists can look at the same virtual slide simultaneously and discuss it — a digital version of the double-headed microscope.
Barcoding and specimen tracking are essential. Because the pathologist may never touch the physical slide, the lab must guarantee that the image on screen belongs to the right patient, block, and stain. Robust labeling, scan quality control, and rescan procedures for blurry or incomplete images are standard parts of a digital workflow.
Main Use Cases
Intraoperative Frozen-Section Consultation
During surgery, a surgeon may need an immediate answer — is this margin clear? is this lymph node involved? — from a frozen section, a rapidly prepared slide read within minutes. Smaller hospitals often cannot staff a pathologist on site for every operating day. Telepathology lets a technologist prepare the frozen section locally while a pathologist at a hub hospital reads it remotely, keeping surgery on schedule without flying specialists between campuses.
Second Opinions and Expert Consultation
Difficult cases — unusual tumors, borderline lesions, rare entities — benefit from subspecialty review. Digital consultation removes the delay and risk of mailing glass slides. Academic centers operate digital consultation services that receive scanned cases from around the world, and a treating pathologist can obtain an expert opinion in hours rather than weeks. For patients, this can mean faster confirmation before major treatment decisions.
Coverage, Workload Balancing, and Quality Assurance
Health systems use digital pathology to distribute work across sites: a network with pathologists in several cities can route cases to whoever has capacity or the right subspecialty expertise. Digital archives also simplify retrospective review, tumor boards, and QA programs, since prior material is a click away rather than in a file room. Education is a further beneficiary — trainees can study annotated virtual slides without competing for a single set of glass teaching slides.
AI-Assisted Image Analysis
Once slides are digital, computational tools can analyze them. Current applications are assistive rather than autonomous: algorithms that flag regions suspicious for prostate cancer so the pathologist reviews them first, tools that count mitotic figures or quantify immunohistochemical stains such as Ki-67 or HER2 more reproducibly than manual estimation, and triage software that prioritizes likely-positive cases in a queue. In the United States these tools are generally regulated as medical devices, and the ones on the market are cleared for use under pathologist supervision. The pathologist remains the diagnostician; the algorithm is closer to a tireless, consistent screening assistant.
Evidence and Honest Limitations
Validation studies comparing WSI diagnosis to conventional microscopy have generally shown high concordance across routine surgical pathology, and that evidence base is why regulators and laboratory accreditors permit primary digital diagnosis. Peer-reviewed literature indexed in PubMed Central includes large multi-site concordance studies alongside years of operational experience from early-adopting health systems, particularly in Europe.
The honest caveats:
- Not every task digitizes equally well. Detecting Helicobacter organisms, malaria parasites, or subtle amyloid deposits, and appreciating fine chromatin detail, can be more difficult on screen. Labs define case types that still trigger glass review, and pathologists can always request the physical slide.
- Image quality is a real variable. Out-of-focus regions, tissue folds, and scanning artifacts occur. Quality control and rescanning procedures are mandatory, not optional.
- Cost and infrastructure are significant. Scanners, storage measured in petabytes for a busy lab, and integration with laboratory information systems require capital and IT commitment that smaller labs may struggle to justify.
- AI tools are only as good as their validation. Algorithms trained on one scanner, stain protocol, or patient population may perform worse elsewhere. Local verification before clinical use is the accepted standard.
Validation and QA Requirements
U.S. laboratories operate under CLIA (the Clinical Laboratory Improvement Amendments), and accreditation programs such as the College of American Pathologists' require a documented validation before WSI is used diagnostically. Expectations include validating the full system — scanner, viewer, display — as actually used; having each pathologist demonstrate concordance between digital and glass readings on a meaningful sample of cases, with a washout period between readings; revalidating when significant components change; and maintaining ongoing QA such as periodic digital-versus-glass rechecks and image-quality monitoring. Remote sign-out locations, including pathologists' homes, must also meet defined standards for displays, connectivity, and security.
Reimbursement and Regulatory Notes
At a high level: pathology is already an indirect specialty — patients rarely meet their pathologist — so telepathology mostly changes where the professional work happens rather than creating a new patient-facing encounter. Professional interpretation is generally billable regardless of whether the read was digital or glass, while consultation services have their own billing pathways. Add-on codes for digital pathology workflows have been introduced in recent years, but payment policy in this area continues to evolve, so laboratories should confirm specifics with CMS and their payers; our overview of telehealth reimbursement explains the broader framework. Licensure is the other major consideration: a pathologist rendering a diagnosis is generally considered to be practicing medicine where the patient is, so interstate services require appropriate state licenses — see telemedicine laws by state for how these rules vary. HIPAA obligations apply to virtual slides and reports like any other health information, as covered in our telehealth security guide.
What Patients Should Expect
Most patients will never directly notice telepathology, but its effects are tangible. A biopsy taken at a community hospital may be read the same day by a subspecialist across the state. A second opinion on a cancer diagnosis can be obtained without tracking down and mailing glass slides. During surgery, a remote frozen-section read may spare a patient a second operation. Patients are entitled to know who interpreted their specimen — the pathologist's name appears on the report — and may request that their slides or digital images be shared for an independent review. The diagnostic standard is the same whether the pathologist sat at a microscope or a workstation.
Where Telepathology Is Heading
The direction of travel is toward fully digital pathology departments, where glass slides are scanned by default and the archive is searchable by image content, not just text. That foundation enables the next phase: AI tools that pre-screen biopsies, standardize biomarker scoring, and eventually help predict treatment response from tissue morphology — always, for the foreseeable future, with a pathologist making the call. As with teleradiology a generation earlier, the likely endpoint is that "tele" quietly disappears from the name: pathology simply becomes a digitally networked specialty, with distance no longer determining who reads a case. For context on how specialty telemedicine fits together, see our overviews of teledermatology and emergency telemedicine.
Frequently asked questions
- Is a diagnosis made from a digital slide as reliable as one made at the microscope?
- For most routine surgical pathology, validation studies have found high concordance between whole-slide imaging and glass-slide diagnosis when labs validate their systems properly. Certain tasks, such as finding microorganisms or grading subtle nuclear features, can be harder digitally, which is why labs keep glass slides available for review.
- Does the FDA regulate telepathology?
- The FDA regulates the devices involved. Whole-slide imaging systems marketed for primary diagnosis in the United States require FDA authorization, and AI-based image analysis tools are typically regulated as medical devices as well. The practice of pathology itself is governed by state licensure and laboratory regulations such as CLIA.
- Can a pathologist in another state read my biopsy remotely?
- Generally yes, if licensure requirements are satisfied. Most states treat a remote diagnosis as practicing medicine where the patient or specimen is located, so the pathologist usually needs a license in that state. Rules vary, so labs verify requirements before setting up interstate services.
- Does AI make the diagnosis in digital pathology?
- No. Cleared AI tools in pathology are assistive: they highlight suspicious regions, quantify biomarkers, or help prioritize cases. A qualified pathologist reviews the findings and remains responsible for the final diagnosis.